We also expose that SETD2, as well as ATG12 gene expression, can present prognostic value for ccRCC patients, where low SETD2 expression but high ATG12 gene expressions are associated with an unfavorable prognosis. Here, ATG12 is linked to nonpapillary renal cell carcinoma.